Last reviewed · How we verify
Famotidine Outpatient COVID-19 Treatment Study
A retrospective case series of patients who self-medicated with Famotidine during coronavirus disease 2019 (COVID-19). The study will collect de-identified patient reported outcome measures of patients with confirmed COVID-19 who self-medicated with Famotidine at any dose during the period of illness. Data will be collected by questionnaire and telephone interview. Inclusion criteria: Age\>18; Ability to give written informed consent for study participation; Confirmed diagnosis of COVID-19; Use of Famotidine at any dose during period of COVID-19 illness
Details
| Lead sponsor | Northwell Health |
|---|---|
| Status | COMPLETED |
| Enrolment | 10 |
| Start date | Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- COVID-19
Interventions
- Famotidine
Countries
United States